B Cell Growth-promoting Activity of Recombinant Human Interleukin 4
Overview
Authors
Affiliations
Human interleukin 4 (IL-4), also known as B cell stimulatory factor 1, is a T cell-derived glycoprotein consisting of 129 amino acids for which a cDNA has been recently isolated. IL-4 displays little or no B cell growth factor (BCGF) activity in the standard anti-IgM costimulatory assay using suboptimal concentrations of soluble anti-IgM antibody whereas the low m.w. BCGF is very active. When insolubilized anti-IgM was used as the costimulating agent, both IL-4 and the low m.w. BCGF were found to promote B cell proliferation. Human IL-4 is able to induce the proliferation of B lymphocytes preactivated for either 1 day with insolubilized anti-IgM antibody or for 3 days with Staphylococcus aureus strain Cowan I. However, IL-4 is poorly mitogenic for B cells preactivated for 1 day with the Staphylococcus strain whereas the low m.w. BCGF strongly enhances the proliferation of these B cells. These two findings demonstrate that the preactivation signal necessary to induce human B cells to proliferate in response to IL-4 is critical. The increased tritiated thymidine ([3H]dThd) uptake in preactivated B cell cultures with IL-4 reflects cel proliferation because cell cycle analysis demonstrates that IL-4 induces activated B cells to enter the S and G2/M phases of the cell cycle and the addition of IL-4 to preactivated B cell cultures permits the recovery of three- to fourfold more B cells after 4 days of culture. IL-4 and the low m.w. BCGF act in concert to induce the proliferation of anti-IgM-preactivated B cells as demonstrated by [3H]dThd uptake and cell cycle analysis. In striking contrast to the demonstrated antagonistic effect of interferon-gamma on the IL-4-induced expression of the low affinity receptor for IgE (Fc epsilon RL/CD23), on B cells, it was found that interferon-gamma enhanced the IL-4-induced proliferation of anti-IgM-preactivated B cells. Finally, it was found that IL-4 had to be present continuously during the culture period to exert an optimal growth-promoting effect on B cell blasts. As a conclusion, IL-4 is able to induce the proliferation of an appropriately activated subpopulation of human B cells.
FitzGerald L, Zhao S, Leonardson A, Geybels M, Kolb S, Lin D Prostate Cancer Prostatic Dis. 2018; 21(2):228-237.
PMID: 29298992 PMC: 6026113. DOI: 10.1038/s41391-017-0029-2.
Fc-glycosylation of IgG1 is modulated by B-cell stimuli.
Wang J, Balog C, Stavenhagen K, Koeleman C, Scherer H, Selman M Mol Cell Proteomics. 2011; 10(5):M110.004655.
PMID: 21372248 PMC: 3098587. DOI: 10.1074/mcp.M110.004655.
Torben W, Ahmad G, Zhang W, Siddiqui A Vaccine. 2011; 29(12):2262-71.
PMID: 21277404 PMC: 3063403. DOI: 10.1016/j.vaccine.2011.01.040.
Ichikawa A, Katakura Y, Teruya K, Hashizume S, Shirahata S Cytotechnology. 2008; 31(1-2):133-41.
PMID: 19003133 PMC: 3449779. DOI: 10.1023/A:1008063903946.
Chen R, Chang C, Wang T, Chen C, Tsai C, Tsai F Endocrine. 2007; 32(2):170-4.
PMID: 18058260 DOI: 10.1007/s12020-007-9027-9.